Genetic Testing & Diagnostics
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 NTRA | Natera, Inc. Common Stock | $28.6b | $186.34 | -5.4% | 2.2M |
 LH | Labcorp Holdings Inc. | $21.3b | $250.40 | -1.4% | 568.7K |
 ILMN | Illumina Inc | $19.3b | $142.57 | -0.5% | 1.8M |
 QGEN | QIAGEN N.V. | $7.0b | $32.98 | -0.9% | 1.8M |
 BLLN | BillionToOne, Inc. Class A Common Stock | $3.6b | $82.54 | -6.1% | 1.1M |
 TXG | 10x Genomics, Inc. Class A Common Stock | $2.8b | $21.18 | -1.6% | 2.7M |
 VCYT | Veracyte, Inc. | $2.7b | $38.48 | -1.1% | 944.8K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.9b | $40.73 | +4.8% | 1.6M |
 NEO | NeoGenomics, Inc. | $1.2b | $8.24 | -1.4% | 1.1M |
 CDNA | CareDx, Inc. | $1.1b | $19.95 | -2.6% | 637.6K |
 AZTA | Azenta, Inc. | $1.1b | $16.02 | -4.6% | 1.4M |
 OPK | Opko Health Inc. | $0.9b | $1.11 | +0.9% | 2.7M |
 PSNL | Personalis, Inc. Common Stock | $0.6b | $6.36 | -5.2% | 1.8M |
 MLAB | Mesa Laboratories Inc | $0.5b | $96.48 | -4.0% | 139.3K |
 PACB | Pacific Biosciences of California, Inc. | $490.6m | $1.12 | -7.4% | 9.3M |
 MYGN | Myriad Genetics Inc | $457.1m | $3.57 | -1.4% | 1.6M |
 FLGT | Fulgent Genetics, Inc. Common Stock | $441.3m | $15.71 | -3.0% | 471.6K |
 PRE | Prenetics Global Limited Class A Ordinary Share | $310.1m | $15.60 | -11.3% | 384.1K |
 ALPS | ALPS Group Inc Ordinary Share | $156.1m | $0.92 | +6.4% | 125.0K |
 IMDX | Insight Molecular Diagnostics Inc. Common Stock | $135.1m | $6.45 | +0.5% | 453.3K |
 BNGO | Bionano Genomics, Inc. Common Stock | $13.2m | $1.15 | -3.4% | 198.3K |
 QUCY | Mainz Biomed N.V. Ordinary Shares | $6.3m | $3.50 | +16.5% | 82.1M |
 BGLC | BioNexus Gene Lab Corp Common stock | $5.0m | $2.13 | +7.6% | 3.0K |